PEOPLE - Atrix (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Atrix (US) has appointed Michael Duncan as vice-president of manufacturing. Previously with Geneva Pharmaceuticals, a division of Ciba-Geigy, Mr Duncan will support the European launch of Atrix' Atrisorb guided tissue regeneration product for periodontal use scheduled for the first quarter of next year (see Clinica No 667, p 18).
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.